Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Adheesh Nargolkar ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Lee Pharma's Compulsory License Application For Saxagliptin Rejected By Indian Patent Office
In an order dated 19 January 2016 (Order), the Controller General of Patents and Trademarks rejected the application for Compulsory License for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
India
23 Jan 2016
2
Pfizer's Patent Application Relating To Rheumatoid Arthritis Drug (Tofacitinib) Rejected By Indian Patent Office
The Indian Patent Office has passed an order on 3 September 2015 rejecting patent application no. 991/MUMNP/2003 to Pfizer Products, Inc. for rheumatoid arthritis drug ‘Tofacitinib'.
India
10 Sep 2015
3
Compulsory License For Astrazeneca's Diabetes Management Drug Saxagliptin?
In a recent development, a compulsory license (CL) application has been filed for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
India
8 Jul 2015
Links to Result pages
 
1